Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyCol controlled release ciclosporin for mild to moderate ulcerative colitis
2008-003169-19Phase 2Completed
- Sponsor
- Sigmoid Pharma
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cyclophosphamide in autoimmune colitis (2 arms), sponsored by Sigmoid Pharma. Primary endpoint: Clinical remission at Week 4. Started Jun 2008; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2008-003169-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003169-19.